Atipamezole

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Atipamezole
Atipamezole.svg
Atipamezole-3D-balls.png
Systematic (IUPAC) name
4-(2-Ethyl-1,3-dihydroinden-2-yl)-3H-imidazole
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Veterinary use only
Identifiers
CAS number 104054-27-5 N
ATCvet code QV03AB90
PubChem CID 71310
ChemSpider 64427 YesY
UNII 03N9U5JAF6 YesY
KEGG D03002 YesY
ChEMBL CHEMBL353972 YesY
Chemical data
Formula C14H16N2 
Mol. mass 212.290 g/mol
 N (what is this?)  (verify)

Atipamezole (brand name Antisedan, Pfizer) is a synthetic α2 adrenergic receptor antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.[1] It has also been researched in humans as a potential anti-Parkinsonian drug.[2]

References[edit]

  1. ^ Pfizer Animal Health ANTISEDAN Product Overview
  2. ^ Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294. 

External links[edit]